Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment

Anticancer Research

Volumn 19, Issue 4 C, 1999, Pages 3543-3548

  Stathopoulos, George P ^a   Dafni, Urania G ^a   Malamos, Nikos A ^a   Rigatos, Sotiris ^a   Kouvatseas, George ^a   Moschopoulos, Nikos ^a  

^a NONE

Author keywords

Induction chemotherapy; Non small cell lung cancer (NSCLC)

Indexed keywords

CISPLATIN; EPIRUBICIN; VINDESINE;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; KIDNEY FAILURE; LEUKOPENIA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; EPIRUBICIN; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE CARE; REMISSION INDUCTION; TIME FACTORS; VINDESINE;

EID: 0033428433     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Livingston RB: Combination chemotherapy of bronchogenic carcinoma, non-oat cell. Cancer Treat Rev 4: 153-165, 1997.
2. Casper ES, Gralla RI, Kelsen DP, Cvitkovic E, Golbey RB: Phase II study of high dose Cis-diammine-dichloroplatinum (II) in the treatment of non- small cell lung cancer. Cancer Treat Rep 63: 2107-2109, 1979.
3. Gralla RJ, Casper ES, Kelsen DT, Cvitkovic E, Magill GB, Krown SE, Golbdy RB: Cis-Platin and Vindesine combination chemotherapy for advanced carcinoma of the lung, randomized trial investigation in two dosage schedule. Ann Intern Med 95: 414-420, 1981.
4. Hoeltgen TM, MacIntyre JM, Perlia CP, Lagakos SW, Stolback LL, Bennett JM: Andriamycin and Cytoxan in the treatment of inoperable lung cancer. Cancer 51: 2005-2012, 1983.
5. Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH: Chemotherapy for metastatic non-small cell bronchogenic carcinoma EST 2575, generation V-a randomized comparison of four Cis-Platin-containing regimens. J Clin Oncol 3: 72-79, 1985.
6. Fran R, Skarin A, Balikian J, Amato D, Leslier N, Malcolm A, Frei E, III: Combination chemotherapy followed by radiation therapy in patients with regional stage III unresectable non-small cell lung cancer. Cancer Treat Rep 69: 587-590, 1985.
7. th Annual Meeting of ASCO, 1989 May 21-23, San Francisco, CA, USA 8: 227, 1989.
8. Holines EC, Gail M, (for Lung Cancer Study Group): Survival adjuvant therapy for stage II and III adenocarcinoma and large-cell undifferentited carcinoma. J Clin Oncol 4: 710-715, 1986.
9. Non-Small Cell Lung Cancer Collaborative Groups: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909, 1995.
10. Burkes RL, Ginsberg RJ, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson G, Cooper JD, Jones D, Lockwood G: Induction chemotherapy with Mitomycin, Vindesine and Cis-Platin for stage III unresectable non-small cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 10: 580-586, 1992.
11. Rousell R, Gv̈mez-Codina J, Camps C, Maestre J, Padille J, Cantv̈ A, Mate JL, Shanrong Li, Roig J, Olazàbal A, Canela M, Ariza A, Sk(cel Z, Morera-Prat J, Abad A: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330: 153-158, 1994.
12. Weiden PL, Piantadosi S: Preoperative chemotherapy (Cis-Platin and Fluorouracil) and radiation therapy in stage III non-small cell lung cancer study group. J Natl Cancer Inst 83: 266-273, 1991.
13. th Annual Meeting of ASCO, 1993 May 16-18, Orlando, FLA, USA, 12: 351, 1993.
14. th Annual Meeting of ASCO, 1992 May 17-19;San Diego CA, USA. Educational Book p.59-64, 1992.
15. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, III, Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323: 940-945, 1990.
16. Crino L, Latini P, Meacci M, Corgna E, Maranzano E, Darwish S, Minotti V, Santucci A, Tonato M: Induction chemotherapy plus high-dose radiotherapy alone in locally advanced unresectable non-small cell lung cancer. Ann Oncol 4: 847-851, 1993.
17. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, Elliot TE, Mailliard JA, Nelimark RA, Maksymiuk AW, Drummond RG, Laurie JA, Kugler JW, Anderson RT: Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 115: 681-686, 1991.
18. Kreisman H, Lisbona A, Olson L, Propert K, Modeas C, Dillman RO, Seagren SL, Green MR: Effect of radiologic stage III substage on non- surgical therapy of non-small cell lung cancer. Cancer 72: 1588-1596, 1993.
19. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, Kaasa S, Pater JL, Quoix E, Rapp E, Tumarello D, Williams J, Woods BL, Bernard JP: Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis. Lancet 342: 19-21, 1993.
20. Bains MS: Surgical treatment of lung cancer. Chest 100: 826-837, 1991.
21. Naruke T, Goya T, Tsuchiya R, Suemash K: The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 46: 603-610, 1988.
22. Sugarbaker DJ: Non-small cell lung cancer surgical approach to staging and therapy. Advances in the treatment of non-small cell lung cancer. 28th Annual Meeting of ASCO, 1992 May 17-19, San Diego CA, USA. Educational Book ASCO 48-58, 1992.